"uuid:ID","name","text","label","id","description","instanceType"
"b342cfeb-8394-4806-8ba8-95901cb129a3","OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","","Objective_1","Main objective","Objective"
"3cfff143-0baf-4fe9-b99e-60cdea00b6f4","OBJ2","To document the safety profile of the xanomeline TTS.","","Objective_2","Safety","Objective"
"b8bd8041-648e-415e-8e3b-8bc10cc27da9","OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","","Objective_3","Behaviour","Objective"
